. The company’s pipeline incorporates 4 scientific-stage therapies. Its most advanced drug prospect is ROS1 inhibitor taletrectinib for managing lung cancer. Nuvation is completing two period two pivotal scientific studies on taletrectinib. IV Percentile: The percentage of days with IV closing down below the current IV value over the https://financefeeds.com/asic-suspends-beacon-wealths-afs-license/